Key facts
- It has raised $42.3M; the latest was PE Growth/Expansion in Mar 2026.
- Notable investors include Excellere Partners, Castle Crow & Company.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Medlogix (Lansdale)
- ·The full record, as it builds
Funding rounds
No funding rounds for Medlogix (Lansdale) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medlogix (Lansdale)
Provider of a comprehensive suite of medical claims management services intended to serve the healthcare industry. The company specializes in leveraging its proprietary technology platform, medical expertise, and structured processes including pre-certification, independent medical exams, medical director review, medical bill and code review, and bill negotiation, enabling auto insurance and workers' compensation carriers, third-party administrators, and government entities to reduce expenses and improve productivity.
- Sector
- Healthcare
- HQ
- Lansdale, PA, United States
- Founded
- 1980
- Employees
- 229
- Website
- medlogix.com/
- Ownership
- Privately Held (backing)
Medlogix (Lansdale) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medlogix (Lansdale) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medlogix (Lansdale) in its N-PORT filings yet. We sweep new filings monthly.